Seroatlas · Human Serome Atlas

ACSF3

Malonate--CoA ligase ACSF3, mitochondrial

Also known as: ACSF3_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q4G176
Gene
ACSF3
Ensembl
ENSG00000176715
Chromosome
16
Canonical length
576 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
Subcellular location
Mitochondria

OverviewNCBI Gene

This gene encodes a member of the acyl-CoA synthetase family of enzymes that activate fatty acids by catalyzing the formation of a thioester linkage between fatty acids and coenzyme A. The encoded protein is localized to mitochondria, has high specificity for malonate and methylmalonate and possesses malonyl-CoA synthetase activity. Mutations in this gene are a cause of combined malonic and methylmalonic aciduria. Alternatively spliced transcript variants have been observed for this gene. [provided by RefSeq, Sep 2013]

Canonical amino-acid sequenceUniProt

576 residues, UniProt reviewed canonical sequence.

>Q4G176|ACSF3
     1  MLPHVVLTFR RLGCALASCR LAPARHRGSG LLHTAPVARS DRSAPVFTRA LAFGDRIALV
    61  DQHGRHTYRE LYSRSLRLSQ EICRLCGCVG GDLREERVSF LCANDASYVV AQWASWMSGG
   121  VAVPLYRKHP AAQLEYVICD SQSSVVLASQ EYLELLSPVV RKLGVPLLPL TPAIYTGAVE
   181  EPAEVPVPEQ GWRNKGAMII YTSGTTGRPK GVLSTHQNIR AVVTGLVHKW AWTKDDVILH
   241  VLPLHHVHGV VNALLCPLWV GATCVMMPEF SPQQVWEKFL SSETPRINVF MAVPTIYTKL
   301  MEYYDRHFTQ PHAQDFLRAV CEEKIRLMVS GSAALPLPVL EKWKNITGHT LLERYGMTEI
   361  GMALSGPLTT AVRLPGSVGT PLPGVQVRIV SENPQREACS YTIHAEGDER GTKVTPGFEE
   421  KEGELLVRGP SVFREYWNKP EETKSAFTLD GWFKTGDTVV FKDGQYWIRG RTSVDIIKTG
   481  GYKVSALEVE WHLLAHPSIT DVAVIGVPDM TWGQRVTAVV TLREGHSLSH RELKEWARNV
   541  LAPYAVPSEL VLVEEIPRNQ MGKIDKKALI RHFHPS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ACSF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
35 nTPM

Expression across tissuesHPA

Tissue

  • thymus: 35 nTPM
  • duodenum: 29 nTPM
  • small intestine: 25 nTPM
  • lymph node: 20 nTPM
  • adrenal gland: 19 nTPM
  • liver: 18 nTPM

Single-cell type

  • tuft cells: 58 nCPM
  • enterocytes: 55 nCPM
  • late spermatids: 52 nCPM
  • hematopoietic stem cells: 46 nCPM
  • paneth cells: 43 nCPM
  • b-cells: 42 nCPM

Immune cell

  • memory B-cell: 30 nTPM
  • MAIT T-cell: 25 nTPM
  • plasmacytoid DC: 25 nTPM
  • classical monocyte: 23 nTPM
  • intermediate monocyte: 23 nTPM
  • gdT-cell: 23 nTPM

Brain region

  • cerebral cortex: 30 nTPM
  • white matter: 29 nTPM
  • thalamus: 27 nTPM
  • cerebellum: 25 nTPM
  • choroid plexus: 25 nTPM
  • medulla oblongata: 25 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ACSF3.

Disease | AllUniProt

Conditions ACSF3 is implicated in, by any mechanism.

Disease | GeneticClinVar

186 pathogenic / likely-pathogenic of 1,113 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.77
gnomAD pLI
0
gnomAD missense Z
-1.3
DepMap mean gene effect
0.14
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ACSF3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ACSF3 as an antibody target. Whether an autoantibody or antibody against ACSF3 could matter depends on whether native ACSF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ACSF3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ACSF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ACSF3. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...